This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Two leading non-profits combine efforts to accelerate cancer immunotherapy for patients globally
First-of-its-kind analysis of the global immuno-oncology clinical landscape from pre-clinical development to regulatory approval provides unprecedented opportunity to advance the field of immuno-oncology to improve patient care.
Fight Colorectal Cancer, Cancer Research Institute announce Cancer Immunology Research article publication discussing CRC immunotherapy advancement
The Cancer Research Institute announced today that it will honor biotechnology company Genentech and real estate developer and philanthropist Bruce Ratner with the 2017 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
Drs. Rafi Ahmed and Thomas F. Gajewski will receive the 2017 William B. Coley Award, and Dr. Shannon Turley will receive the 2017 Frederick W. Alt Award.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with advanced cervical cancer.
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.